TRACY KRAMER: Open Payments
NPI 1548371438 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,615 in 98 payments from 25 companies in 2025. Trend: 2023 $1,435 · 2024 $2,196 · 2025 $3,615
Food & beverage: $3,615
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $529 |
| Lilly USA, LLC | 10 | $488 |
| GENZYME CORPORATION | 4 | $413 |
| Phathom Pharmaceuticals, Inc. | 8 | $314 |
| AstraZeneca Pharmaceuticals LP | 6 | $307 |
| Amgen Inc. | 11 | $257 |
| SANOFI-AVENTIS U.S. LLC | 5 | $156 |
| Kowa Pharmaceuticals America, Inc. | 4 | $148 |
| Astellas Pharma US Inc | 2 | $141 |
| Novo Nordisk Inc | 5 | $136 |
Products named: DUPIXENT, VOQUEZNA, VRAYLAR, QULIPTA, MOUNJARO, TZIELD, ZORYVE, Veozah.
Industry payments across TX — which companies pay providers there.
